title: Plant-based diets relatively low in bioavailable phosphate and calcium may aid prevention and control of prostate cancer by lessening production of fibroblast growth factor 23.
abstract: Fibroblast growth factor 23 (FGF23), a hormonal regulator of phosphate and vitamin D metabolism produced primarily in bone by osteocytes and mature osteoblasts, is now known to have growth factor activity for many prostate cancers. In some of these cancers, autocrine production of FGF23 drives their proliferation. FGF23 synthesized within bone likely promotes the expansion of prostate cancer bone metastases. Hence, dietary or lifestyle factors which boost bone's production of FGF23 may encourage the induction and spread of prostate cancer. High dietary intakes of bioavailable phosphorus and of calcium have been found to boost FGF23 levels, and this accords well with prospective epidemiology pointing to high intakes of both phosphate and calcium as risk factors for aggressive prostate cancer. Hence, prospective studies correlating baseline FGF23 levels with subsequent risk for prostate cancer, or advanced prostate cancer, are needed. Natural plant-based diets, though not inherently low in calcium or phosphorus, provide forms of these that are less bioavailable than those in animal products, and hence may be expected to down-regulate bone's production of FGF23. This may play a role in the lower risk for clinical prostate cancer observed in vegans and quasi-vegan cultures. Other factors, such as decreased IGF-I levels and mTORC1 activity, may also play a role in this regard.
authors.affiliation: Catalytic Longevity, 7831 Rush Rose Dr., Apt. 316, Carlsbad, CA 92009, USA. Electronic address: markfmccarty@gmail.com.
authors.forename: Mark F
authors.initials: MF
authors.lastname: McCarty
mesh_terms: D000818:Animals; D002118:Calcium / Q000378:metabolism*; D004032:Diet; D000067269:Diet, Vegan; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000378:metabolism*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008297:Male; D000076222:Mechanistic Target of Rapamycin Complex 1; D008962:Models, Theoretical; D046912:Multiprotein Complexes / Q000378:metabolism; D009362:Neoplasm Metastasis; D010006:Osteoblasts / Q000378:metabolism*; D010011:Osteocytes / Q000166:cytology / Q000378:metabolism*; D010710:Phosphates / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000378:metabolism* / Q000517:prevention & control; D051381:Rats; D012307:Risk Factors; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism; D014807:Vitamin D / Q000378:metabolism
chemical_list: C000717427:FGF23 protein, human; D046912:Multiprotein Complexes; D010710:Phosphates; D014807:Vitamin D; D005346:Fibroblast Growth Factors; D007334:Insulin-Like Growth Factor I; D000089703:Fibroblast Growth Factor-23; D000076222:Mechanistic Target of Rapamycin Complex 1; D058570:TOR Serine-Threonine Kinases; D002118:Calcium
keywords: Calcium; FGF23; Phosphate; Plant-based diet; Prostate cancer; Vegan